Form 4: Aspen Aerogels Executive Virginia Johnson Reports Stock and Options Award

Sentiment:

SEC Form 4 Filing


Virginia Johnson, CLO, GC, Secretary & CCO of Aspen Aerogels, reports the acquisition of stock and options.

Summary

  • On March 5, 2024, Virginia Johnson, CLO, GC, Secretary & CCO of Aspen Aerogels, acquired 8,032 shares of common stock and 35,249 stock options.
  • The stock was acquired at a price of $0.
  • The options have an exercise price of $16.34.
  • The shares and options vest in three equal installments on March 5, 2025, March 5, 2026, and March 5, 2027.
  • Following the transaction, Johnson directly owns 29,923 shares of common stock (including 28,521 RSUs) and 35,249 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock and options is a standard practice and suggests confidence in the executive's future contributions. The vesting schedule promotes long-term alignment.

Positives

  • The granting of stock and options to a key executive aligns their interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The vesting schedule suggests an expectation of continued service and contribution from the executive over the next three years.

Industry Context

Stock and option grants are a common practice in publicly traded companies to incentivize and retain key executives.

Comparison to Industry Standards

  • Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies, particularly in growth-oriented sectors like Aspen Aerogels' industry.
  • Comparing the vesting schedule and option exercise price to similar companies in the materials or energy technology sectors would provide a benchmark for assessing the competitiveness and reasonableness of this compensation package.
  • Companies like Cabot Corporation, Rogers Corporation, or even technology firms with advanced materials divisions could serve as relevant comparison points.

Stakeholder Impact

  • Shareholders may view the stock and option grants as a positive sign, aligning management's interests with theirs.
  • Employees may see this as a positive indicator of the company's commitment to its leadership.

Key Dates

DateDescription
03/05/2024Date of transaction: Acquisition of stock and options.
03/05/2025First vesting date for one-third of the shares and options.
03/05/2026Second vesting date for one-third of the shares and options.
03/05/2027Final vesting date for the remaining one-third of the shares and options.
03/07/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.